Excretion of Wild-Type and Vaccine-Derived Poliovirus in the Feces of Poliovirus Receptor-Transgenic Mice
Open Access
- 1 June 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (11) , 6541-6545
- https://doi.org/10.1128/jvi.77.11.6541-6545.2003
Abstract
The emergence of circulating vaccine-derived poliovirus (cVDPV) strains in suboptimally vaccinated populations is a serious threat to the global poliovirus eradication. The genetic determinants for the transmissibility phenotype of polioviruses, and in particularly of cVDPV strains, are currently unknown. Here we describe the fecal excretion of wild-type poliovirus, oral polio vaccine, and cVDPV (Hispaniola) strains after intraperitoneal injection in poliovirus receptor-transgenic mice. Both the pattern and the level of fecal excretion of the cVDPV strains resemble those of wild-type poliovirus type 1. In contrast, very little poliovirus was present in the feces after oral polio vaccine administration. This mouse model will be helpful in elucidating the genetic determinants for the high fecal-oral transmission phenotype of cVDPV strains.Keywords
This publication has 15 references indexed in Scilit:
- Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infectionJournal of General Virology, 2002
- Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic DiseaseJournal of Virology, 2002
- Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived PoliovirusScience, 2002
- Progress toward global eradication of poliomyelitis, 2001.2002
- Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001.2001
- Genomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary VaccineesJournal of Virology, 2001
- Circulation of a type 2 vaccine-derived poliovirus--Egypt, 1982-1993.2001
- Mucosal and Systemic Immunity against Poliovirus in Mice Transgenic for the Poliovirus Receptor: The Poliovirus Receptor Is Necessary for a Virus‐Specific Mucosal IgA ResponseThe Journal of Infectious Diseases, 2000
- Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitisPublished by Elsevier ,1990
- Vaccine-Associated Paralytic PoliomyelitisJAMA, 1987